B-LCL-HROC57 Cells
USUSD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | B-LCL-HROC57 is an Epstein-Barr virus (EBV)-immortalized human B lymphoblastoid cell line established from tumor-infiltrating B cells (TiBc) isolated from a primary colorectal carcinoma designated HROC57. The parental tumor originated from an adult male patient with right-sided colorectal carcinoma exhibiting neuroendocrine differentiation and advanced-stage disease. Fresh tumor tissue was mechanically dissociated to obtain single-cell suspensions, and B cells were selectively immortalized in vitro using EBV-containing supernatant derived from the B95/8 marmoset cell line in the presence of cyclosporin A to inhibit T- and NK-cell outgrowth. Long-term expansion yielded a stable monoclonal B-cell culture, as confirmed by immunoglobulin gene rearrangement analysis. B-LCL-HROC57 secretes immunoglobulin G (IgG) as its exclusive isotype, with stable production over prolonged culture. In cell-based binding assays, IgG derived from B-LCL-HROC57 demonstrates measurable binding to allogeneic colorectal carcinoma cell lines, with intermediate binding intensity relative to other TiBc-derived IgGs. Immunofluorescence analyses indicate predominantly intracellular target recognition in tumor cells. No spontaneous B-cell outgrowth occurs in the absence of exogenous EBV during culture establishment, excluding latent EBV-driven transformation in vivo. As a monoclonal, antigen-experienced tumor-infiltrating B-cell line, B-LCL-HROC57 represents a defined model for investigating humoral immune responses in colorectal carcinoma and for identifying tumor-associated antigens recognized by locally expanded B-cell clones. |
|---|---|
| 生物體 | Human |
| 組織 | Peripheral blood |
| 疾病 | Carcinoma |
| 同義詞 | Bc HROC57, TiBcHROC57 |
特徵
| 年齡 | 43 years |
|---|---|
| 性別 | Male |
| 族裔 | Caucasian |
| 形態學 | Round cells |
| 細胞類型 | B lymphoblast |
| 生長特性 | Suspension |
監管數據
| 引用 | B-LCL-HROC57 (Cytion catalog number 302072) |
|---|---|
| 生物安全等級 | 2 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_A7UR |
生物分子資料
| 表面抗原 | CD19 |
|---|---|
| 病毒 | Transformant: EBV |
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% heat-inactivated FBS |
| 傳代培養 | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|